Global Colon Cancer Association | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

111,425 results for “Global Colon Cancer Association”

Trials

View all 83776 →

COLON-MD: Colon Cancer Longitudinal Study

11 participants · First posted Feb 12, 2021

The Association Between the Microbiological Environment in Colon and Colorectal Disease

1,257 participants · First posted Oct 5, 2017

Active, not recruiting

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer

100 participants · First posted Mar 21, 2019

Drugs

View all 2333 →

colon cancer therapy (NCI)

VPS34 inhibitor (Global Cancer Technology/Barrow Neurological Insitute/Neuropore Therapies)

siRNA agent (colon cancer)

Organizations

View all 1397 →

SWEET CHEEKS COLON CARE PTY LTD

Australia

EUROBLOODNET ASSOCIATION

France

Maniilaq Association

United States

News

View all 23919 →

Global Colon Cancer Association to Host Webinar on HER2-Positive Colorectal Cancer and Biomarker Testing for Patient Advocates

Most Favored Nation Drug Pricing Proposal Threatens Patient Access and Pharmaceutical Innovation, Experts Warn

CRISPR-Based Immunotherapy Achieves Complete Remission in Terminal Colon Cancer Patient

Page 1 of 11143